Atrial Fibrillation: New Drug Treatment After Stent Surgery

We are studying whether a simpler medication regimen can safely prevent blood clots and serious heart issues in patients with irregular heartbeat after coronary stent implantation. This trial compares it to the current standard treatment involving multiple medications.

>2 years≤5 visitsConfirmation phase (III)No PlaceboPartially RemoteStandard MedicinesOralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Apixaban
Apixaban is a medicine that helps prevent dangerous blood clots and reduces the risk of stroke in people with an irregular heart rhythm.
Clopidogrel
Clopidogrel is a medicine used to prevent harmful blood clots and reduce the risk of stroke and heart attack.
Edoxaban
Edoxaban is a medicine that thins the blood to help prevent strokes in people with irregular heartbeat and treat or prevent harmful blood clots.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Acetylsalicylic Acid
Acetylsalicylic acid is a substance that reduces pain, fever, and inflammation and can help prevent blood clots.
Apixaban
Apixaban is a substance that helps prevent harmful blood clots and lowers stroke risk in people with irregular heart rhythm.
Clopidogrel
Clopidogrel is a substance that helps prevent blood clots by stopping platelets from sticking together, lowering the risk of heart attack and stroke.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abatixent
Abidalo
Aboxoma

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Jessa Ziekenhuis
Cardiology
Hasselt, Belgium
CHU de Charleroi Hopital Civil Marie Curie
Cardiology
Lodelinsart, Belgium
Az St-Jan Brugge-Oostende A.V.
Cardiology
Sint-Andries, Belgium
Sponsor: Insel Gruppe AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.